Does Dr. Mudhasir Ahmad consult online?

Yes, Dr. Mudhasir Ahmad does online consult. Patient can select Tele-consult or At Hospital while submitting the appointment request.

What is the specialty of Dr. Mudhasir Ahmad?

Dr. Mudhasir Ahmad specialty is Medical Oncologist

What is the experience of Dr. Mudhasir Ahmad?

Dr. Mudhasir Ahmad is Medical Oncologist with 14 years of experience.

What does a medical oncologist do?

A medical oncologist treats cancer using chemotherapy or other medications such as targeted therapy or immunotherapy.

What are the typical symptoms of cancer?

There may be Change in bowel or bladder habit, sore that does not heal, Unusual bleeding or discharge, Thickening or lump in the breast or elsewhere, Indigestion or difficulty in swallowing, Obvious change in a wart or mole and hoarseness in voice.

Which tests/ investigations are generally required by the medical oncologist ?

Tests like Biopsy, Bone Marrow Aspiration and Biopsy, Bone Scan, Breast MRI, Colonoscopy, Computed Tomography (CT) Scan, Digital Rectal Exam (DRE) etc are performed.

How long does the chemotherapy session lasts?

Chemotherapy session varies in length and frequency, it depends on the individual treatment plan prescribed by the doctor. Some last as long as three or four hours, while others may only take an half-hour.

What is the difference between a surgical oncologist and a medical oncologist?

A medical oncologist treats cancer using chemotherapy or other medications, such as targeted therapy or immunotherapy wheras the surgical oncologist removes the tumor and nearby tissue during surgery.

Dr. Mudhasir Ahmad, Medical Oncologist in Noida, India - Appointment

About Dr. Mudhasir Ahmad

Dr. Mudhasir Ahmad is a renowned Medical Oncologist with experience of more than 14 years
He has expertise in the treatment of Immunotherapy, Targeted therapy, and genetic mutation-based therapy, and cancers of the breast, gynecological (ovarian, cervix, uterine), lung, gastrointestinal, head and neck, lymphomas, myeloma, molecular therapy, endocrine therapy and
advanced chemotherapy.
He is an active member of the American Society of medical oncology, European Society of Medical Oncology, Medical oncologists federation of A P, India, International Association for the Study of Lung Cancer, Indian society of medical and pediatric oncology and Delhi Oncology Forum.
He has received the Indian Council of Medical Research (ICMR) grant for a research presentation in Barcelona, Spain.
Dr. Ahmad has several publications in international as well as national journals.

Hospital

Location

Noida, India

Special Interest

Malignant hematology, Immunotherapy, Targeted therapy

Book Appointment Contact Doctor

Work Experience of Dr. Mudhasir Ahmad

Consultant, Fortis Escorts Hospital, Faridabad

Consultant, HCG (Healthcare Global), Delhi

Consultant, Apollo Hospitals, Jubilee Hills Hyderabad

Senior Registrar, Indraprastha Apollo Hospital, New Delhi

Senior Consultant, Jaypee Hospital, Noida

MBBS

Hospital-based observational study on the tolerability, and efficacy of two Gemcitabine Oxaliplatin regimens Abstract. Annals of Oncology 24 (4): iv38–iv121, 2013
Hypercvad+Bortezomib Is a Well Tolerated Salvage Regimen for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia. Blood (ASH- American Society of Hematology- Annual Meeting Abstracts) 2010 116: Abstract 4345.
High Sensitivity C- Reactive Protein in the Male Patients with Angina with Normal Coronary Arteries. IJHSR. 2014; 4(4): 69-79
An Unusual Case of Refractory Seizure Disorder; An Insight into the Cause of Delayed Presentation of Functional Insulinoma. Austral - Asian Journal of Cancer ISSN-0972-2556, Vol. 13, No. 2, April 2014
Pulmonary artery thrombosis mimicking disease progression in metastatic renal cell carcinoma while on sunitinib. Published in Indian Journal of cancer in Jan-Mar, 2016, and a poster presentation in 31st ICON CONFERENCE Bhopal, MP, India. September 12, 2014. DOI: 10.4103/0019-509X.180852
Posterior reversible encephalopathy syndrome, the most uncommon adverse effect of one the commonest chemotherapy regimens, FOLFOX. Apollo Medicine March 2015. Published by Elsevier. Apollo medicine 12 (2015) 54-5 6
Infections in Hematopoietic Stem Cell Transplantation Recipients in the Pre-Engraftment Period. Global Journal of Hematology and Blood Transfusion, 09 January 2015. ISSN (online): 2408-9877

Wondering where to start?

(Get Free opinion, Quote, Medical Visa Invitation and Assistance at every step of your treatment.)

Send Enquiry

Book Appointment Contact Doctor

Dr. Mudhasir Ahmad Chat

Medical Oncologist

Senior Consultant